Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...

The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...

Pharmaceuticals announced that the European Medicines Agency’s, EMA, Committee for Medicinal Products for Human Use, CHMP, has ...

Meghan Markle’s brand drama continues. The Duchess of Sussex, 43, is facing possible legal action from a Spanish town over the logo of her new lifestyle business, As Ever, which she announced ...

Meghan Markle’s new brand logo has a thoughtful nod to her relationship with Prince Harry. The Duchess of Sussex, 43, announced plans to rename her lifestyle brand, American Riviera Orchard ...

Logo Brands Secures Exclusive Rights to Produce and Distribute University of Texas Tailgate Gear, Throws, and Sports Balls. FRANKLIN, TENNESSEE / ACCESS Newswire / February 19, 2025 / Logo Brands ...

Regeneron on Friday said the recommendation covers adults with adults with relapsed and refractory multiple myeloma who have received at least three prior therapies, including a proteasome inhibitor, ...

Linvoseltamab's BLA resubmission is under FDA review, with a decision anticipated by July 2025, supported by LINKER-MM1 trial data. The trial evaluates linvoseltamab's safety, tolerability, and ...

The BLA is supported by data from the pivotal LINKER-MM1 trial investigating linvoseltamab in R/R MM, and linvoseltamab is also under review by the European Medicines Agency (EMA) for the same ...

Linvoseltamab is an investigational B-cell maturation antigen CD3-targeted bispecific antibody. The BLA resubmission was needed as the original application could not be approved due to manufacturing ...

Eagle-eyed social media users spotted a striking resemblance between Meghan Markle's new brand logo and a Spanish coat of arms. The Duchess of Sussex uploaded a new video on her Instagram account ...